Tag: IgA Nephropathy

May 9, 2018

Reata Pharmaceuticals Announces First Quarter 2018 Financial Results and an Update on Development Programs

Reata Pharmaceuticals (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today provided an update on the Company’s product development programs and announced financial...
April 10, 2017

Anthera Finished Dosing In Clinical Study

Anthera Pharmaceuticals completed the dosing of a recent randomized, double-blind, placebo-controlled clinical study of blisibimod on patients with Berger's disease.